Connect with us

Hi, what are you looking for?

Daily Market SolutionDaily Market Solution

Latest News

Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid

Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid, will face questions in front of the Senate Committee on Finance Friday morning. 

Following the hearing, the committee will schedule a vote to send Oz’s nomination to the full Senate, where approval is likely, considering the Republican majority.

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania. 

Oz is expected to be grilled by Democrats during the hearing over his financial ties to a myriad of healthcare-related companies, several of which pose potential conflicts of interest for the potential CMS director.

Oz has committed to divesting many of his financial interests that pose the most obvious risk of impropriety, such as his hundreds of thousands of dollars in stock in United Health Group, a major private health insurer. He also said that if he were confirmed, he would forfeit the nearly $25 million in stock options he obtained as an advisor to a company selling health and beauty supplements.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services. 

On Thursday, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were approved in committee and will now face impending votes by the full Senate.

This post appeared first on FOX NEWS







    You May Also Like

    Editor's Pick

    Extremist supporters of former president Donald Trump are lashing out online against Usha Vance, the wife of Trump’s running mate, Sen. J.D. Vance (R-Ohio),...

    Investing

    Overview Energy Fuels (TSX:EFR,NYSE:UUUU) has been the largest producer of uranium in the United States and an emerging producer of rare earth elements (REEs)....

    Investing

    Investor Insight Silver prices breached $30/oz in the second half of May 2024 as investor demand drove prices to their highest in more than...

    Investing

    Overview Flynn Gold Limited (ASX: FG1) is an Australian mineral exploration company with a portfolio of projects in Tasmania and Western Australia. Tasmania is...

    Disclaimer: Dailymarketsolution.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 dailymarketsolution.com